One study found that the cytoplasmic domain of ICAM2 interacts with the cytoskeletal linker protein α-actinin; this interaction promotes the non-metastatic phenotype of ICAM2 in neuroblastoma cells [15]. Here, ICAM2 is linked to neuroblastoma.